摘要
目的观察稳心颗粒联合小剂量胺碘酮治疗心律失常的临床疗效及安全性。方法选择心律失常患者100例,随机分成两组,每组各50例,对照组给予大剂量的胺碘酮治疗,治疗组给予稳心颗粒联合小剂量胺碘酮治疗。疗程均为4周,观察两组临床疗效及不良反应发生情况。结果临床总有效率和早搏总有效率对照组为80.00%和70.00%,治疗组为92.00%和88.00%;不良反应对照组有9例,治疗组有4例。结论稳心颗粒联合小剂量胺碘酮治疗心律失常疗效较好、不良反应少,值得临床推广。
Objective To study the clinical efficacy and safety of Wenxin Granules combined low dose amiodarone in the treatment of arrhythmia. Methods 100 patients with arrhythmia were randomly divided into two groups, 50 cases in each group. The control group was treated by large- dose amiodarone,while the treatment group received Wenxin Granules combined low- dose amiodarone. The treat- ment course in the two groups was 4 weeks. The clinical efficacy and adverse events were observed. Results The clinical total effective rate and the total effective rate of premature beat was 80.00% and 70.00% in the control group,and 92.00% and 88.00% in the treatment group, respectively. The control group had 9 cases of adverse reactions and the treatment group had 4 cases. Conclusion Wenxin Granules combined with low- dose amiodarone has a good effect and less adverse reactions in the treatment of arrhythmia and is worthy of clinically promoted.
出处
《中国药业》
CAS
2012年第20期101-102,共2页
China Pharmaceuticals
关键词
稳心颗粒
胺碘酮
心律失常
Wenxin Granules
amiodarone
arrhythmia
